AIxC Hub Surpasses 4.8M Registered Wallets, Introduces New Season, and Announces "Agentir" for AI Agents [Accessibility Statement] Skip NavigationLOS ANGELES, Feb. 26, 2026 /PRNewswire/ -- AIxCrypto Inc. (NASDAQ: AIXC, "AIxC" or the "Company"), a U.S.-Nasdaq listed company integrating AI and blockchain while bridging Web2 and Web3, today announced AIxC Hub's expanded ecosystem growth, newest season, and the planned launch of "Agentir", a performance evaluation environment for AI Agents.Continue Reading- Age ...

[https://mb.cision.com/Public/15728/4313178/b79ae34c93871998.pdf]20260226 Oncoinvent 2H 2025 report[https://mb.cision.com/Public/15728/4313178/b034e378391f908e.pdf]20260226 Oncoinvent 2H25 presentationSOURCE Oncoinvent ASA## 21%[more press release views with Request a Demo]---- -- Oncoinvent ASA: Second half 2025 results [Accessibility Statement] Skip NavigationOSLO, Norway, Feb. 26, 2026 /PRNewswire/ -- Oncoinvent (OSE: ONCIN), a biotech company developing a receptor-independent alpha radiopharmaceutical t ...

Core Viewpoint - Halper Sadeh LLC is investigating potential breaches of fiduciary duties by certain officers and directors of Five9, Inc., encouraging shareholders to contact the firm to discuss their rights and possible corporate governance reforms [1]. Group 1: Shareholder Rights and Legal Actions - Shareholders of Five9, Inc. may seek corporate governance reforms, return of funds, court-approved financial incentives, or other benefits [1]. - The firm operates on a contingent fee basis, meaning shareholders would not incur out-of-pocket legal fees [1]. Group 2: Importance of Shareholder Involvement - Shareholder participation is crucial for improving company policies, practices, and oversight, which can enhance overall shareholder value [1]. - Halper Sadeh LLC has a history of representing investors globally who have experienced securities fraud and corporate misconduct, recovering millions for defrauded investors [1].

Core Insights - LG Display has achieved the industry's first "100% dimming consistency" verification for its large-sized OLED panels, demonstrating superior pixel-level dimming technology [1] - This verification from UL Solutions highlights the effectiveness of OLED technology in maintaining brightness consistency across varying screen areas, unlike LCD panels which show significant dimming [1] Group 1: Dimming Consistency - Dimming consistency measures how effectively a display reproduces content based on brightness performance, with OLED achieving a perfect score of 100% [1] - In contrast, LCD panels showed a dimming consistency that dropped from a maximum of 83% to as low as 43% as the test area decreased [1] Group 2: Technology Comparison - OLED panels emit light at the pixel level, allowing them to maintain brightness and reproduce natural colors, while LCD technology struggles with color accuracy due to larger backlight blocks [1] - The halo effect in LCD panels can cause light bleeding, resulting in blurred images, particularly when bright objects are rendered against dark backgrounds [1] Group 3: Future Plans and Innovations - LG Display aims to strengthen its leadership in large-sized OLED technology, introducing new panels that utilize "Primary RGB Tandem 2.0" technology, achieving peak luminance of up to 4,500 nits [1] - The new technology also features the lowest reflectance level (0.3%) among existing displays, enhancing visual clarity [1]

Core Viewpoint - Halper Sadeh LLC is investigating potential breaches of fiduciary duties by certain officers and directors of Dentsply Sirona Inc., encouraging shareholders to contact the firm regarding their rights and possible corporate governance reforms [1]. Group 1: Investigation and Shareholder Rights - The law firm is looking into whether Dentsply Sirona's management has acted against the interests of shareholders [1]. - Long-term shareholders may seek various forms of relief, including corporate governance reforms and financial incentives [1]. - Shareholder involvement is emphasized as a means to improve company policies and enhance shareholder value [1]. Group 2: Legal Representation and Fees - Halper Sadeh LLC operates on a contingent fee basis, meaning shareholders would not incur out-of-pocket legal fees [1]. - The firm has a history of representing investors globally who have experienced securities fraud and corporate misconduct [1]. - The attorneys at Halper Sadeh LLC have successfully implemented corporate reforms and recovered significant amounts for defrauded investors [1].

Core Viewpoint - A securities fraud class action lawsuit has been filed against NuScale Power Corporation, alleging material misstatements regarding its commercialization strategy for nuclear power generation projects [1] Summary by Relevant Sections Lawsuit Details - The lawsuit is filed on behalf of investors who purchased NuScale Class A common stock between May 13, 2025, and November 6, 2025 [1] - The deadline for investors to seek lead plaintiff status is April 20, 2026 [1] - The case is filed in the United States District Court for the District of Oregon, titled Truedson v. NuScale Power Corporation, et al, Case No. 3:26-cv-00328 (D. Or.) [1] Allegations - The complaint alleges that NuScale made false or misleading statements and failed to disclose that ENTRA1 Energy LLC had no significant experience in building or operating nuclear power projects [1] - It is claimed that NuScale entrusted its commercialization and deployment of its power module to ENTRA1, which lacked relevant experience [1] - The lawsuit also states that the qualifications attributed to ENTRA1 were actually related to the Habboush Group, another entity without significant nuclear experience [1] - As a result, NuScale's commercialization strategy faced undisclosed risks of failure, delays, and regulatory challenges [1] Financial Impact - On November 6, 2025, NuScale reported a significant increase in general and administrative expenses, which rose over 3,000% to $519 million from $17 million in the previous year [1] - This increase was largely due to a $495 million payment to ENTRA1 for a TVA agreement [1] - Consequently, NuScale's quarterly net loss surged to $532 million, compared to $46 million in the prior year [1] - Following this announcement, NuScale's stock price dropped by $5.45 per share, or approximately 14.4%, closing at $32.46 on November 6, 2025 [1] Investor Actions - Investors are advised to retain counsel or contact Kessler Topaz Meltzer & Check, LLP for a free case evaluation [1] - They can also file to be lead plaintiff by the April 20, 2026 deadline [1] - The lead plaintiff will represent the class in directing the litigation and selecting counsel [1]

Core Viewpoint - Omnicom has announced the pricing of public offerings for senior notes totaling $1.7 billion in the U.S. and €600 million in Europe, aimed at refinancing existing debt and supporting general corporate purposes [1]. USD Notes Offering - The USD Notes consist of three tranches: $600 million of 5.300% Senior Notes due 2036, $700 million of 5.000% Senior Notes due 2033, and $400 million of 4.200% Senior Notes due 2029 [1]. - The offerings are expected to close on March 2, 2026, pending customary closing conditions [1]. - The net proceeds will be used to repay $1.4 billion of 3.600% Senior Notes due April 15, 2026, and for general corporate purposes, including working capital, acquisitions, and debt refinancing [1]. Euro Notes Offering - The Euro Notes offering includes €600 million of 3.850% Senior Notes due May 2, 2034, fully guaranteed by Omnicom [1]. - The Euro Notes will rank equally with existing and future unsecured senior indebtedness [1]. - An application will be made for the Euro Notes to be listed on The New York Stock Exchange, subject to approval [1]. Underwriters - Citigroup Global Markets Inc. and Deutsche Bank Securities Inc. are joint global coordinators and book-running managers for the USD Notes offering [1]. - Citigroup Global Markets Limited and Deutsche Bank AG, London Branch are joint global coordinators for the Euro Notes offering [1].

Core Insights - Genomma Lab Internacional reported a challenging year in 2025, with like-for-like sales declining by -4.3% due to a weak summer beverage season and a softer consumption environment in Mexico [1] - The company achieved a year-end EBITDA margin of 23.4%, demonstrating strong business fundamentals despite topline pressure [1] - Genomma Lab anticipates that growth initiatives will gain traction in the second half of 2026, supporting a recovery in operational leverage [1] Financial Performance Summary - Q4 2025 net sales decreased by -13.9% to MXN 4,017 million, while full-year net sales fell by -5.7% to MXN 17,541 million [1] - Gross profit for Q4 2025 was MXN 2,449 million, a decline of -16.7% year-over-year, with a full-year gross profit of MXN 11,022 million, down -7.6% [1] - Net income from continuous operations decreased by -23.1% for the full year 2025, totaling MXN 1,607 million, and declined by -13.0% in Q4 2025 to MXN 319 million [1] Operational Highlights - The company unlocked MXN 1.1 billion in productivity savings to reinvest in growth initiatives, including product innovation and distribution expansion [1] - The cash-conversion cycle remained healthy at 107 days, indicating effective management of working capital [1] - Despite a -2.2% decline in Mexico sell-out during Q4, underlying consumer demand was confirmed to be resilient [1]

Core Viewpoint - A class action lawsuit has been announced against Snowflake Inc. for securities fraud, involving purchasers of Class A common stock between June 27, 2023, and February 28, 2024, with the opportunity for investors to serve as lead plaintiffs [1]. Group 1: Lawsuit Details - The lawsuit claims that during the class period, Snowflake's management made positive statements about business performance while failing to disclose significant negative impacts on consumption and revenues due to product efficiency gains and pricing strategies [1]. - Investors who purchased Snowflake Class A common stock during the specified period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - The Rosen Law Firm, which is leading the lawsuit, has a strong track record in securities class actions, having recovered hundreds of millions of dollars for investors in the past [1]. Group 2: Next Steps for Investors - Interested investors can join the class action by visiting the provided link or contacting the law firm directly for more information [1]. - A lead plaintiff must be appointed by April 27, 2026, to represent the interests of the class members in the litigation [1]. - Until a class is certified, investors are not represented by counsel unless they retain one, and they may choose to remain absent from the class [1].

Core Viewpoint - Nutex Health, Inc. is set to release its Annual Report for the fiscal year ended December 31, 2025, on March 5, 2026, and will hold an earnings conference call on March 6, 2026, to discuss financial performance and business updates [1]. Company Overview - Nutex Health, Inc. is a physician-led integrated healthcare delivery system with 27 micro hospitals and outpatient departments across 12 states [1]. - The company operates two divisions: a Hospital Division, which includes micro-hospitals and specialty hospitals, and a Population Health Management Division, which manages provider networks [1]. Financial Reporting - The Annual Report on Form 10-K will be filed after market close on March 5, 2026, with a press release summarizing financial results issued on the same day [1]. - The earnings conference call is scheduled for March 6, 2026, at 9:30 a.m. CT, where the company will provide insights into its financial performance [1]. Conference Call Details - Participants can join the conference call by dialing 1-877-407-9208 or 1-201-493-6784 [1]. - A transcript and recording of the call will be available on the company's website under "Investor Materials" following the event [1].